Molecular imaging (MI) may be defined as imaging in vivo using molecules that report on
biologic function. This review will focus on the clinical use of radioactive tracers …

Positron emission tomography (PET) with [18F] fluorodeoxyglucose (FDG) has been
established as a useful tool in the management of patients with non-small cell lung cancer …

An estimated 180,000 new cases of lung cancer will be diagnosed in the United States this
year, and lung cancer accounts for approximately 25% of all cancer deaths. The overall 5 …

Positron emission tomography (PET) is emerging as a powerful tool that complements
conventional radiologic assessment (chest radiographs, CT scans, MR imaging) of thoracic …

Methods currently used to assess lung and airway inflammation are often poorly
quantitative, invasive, nonspecific, or insensitive. Positron emission tomography (PET) with …

Dynamic positron emission tomography (PET) imaging of the lung using the radiotracer 2-
[fluorine-18]-fluoro-2-deoxy-D-glucose (18F-FDG) is an emerging method to assess …

The d-glucose analog 2-(fluorine-18)-fluoro-2-deoxy-d-glucose (FDG) is the most commonly
used radionuclide in positron emission tomography (PET) of lung cancer. FDG-PET is a …

Over the past several years, positron emission tomography (PET) has become a clinically
useful, noninvasive study which complements conventional imaging (chest radiographs …

An estimated 180,000 new cases of lung cancer will be diag nosed in the US this year, and
lung cancer accounts for approximately 25% of all cancer deaths. Most lung cancers are …

Abstract Purpose of Review The main goal of the article is to familiarize the reader with
commonly and uncommonly used nuclear medicine procedures that can significantly …